I have taking Atarax and I feel it is doing me good before I sleep.
Saturday, August 18, 2018
Friday, August 17, 2018
Thursday, August 16, 2018
I Think I will learn Java
People that know how to build websites know it. I have to update myself because HTML is a competently different language
from JAVA. I will start learning.
ATB
He is one of the pioneers to start Dance music. Along time ago this kind of music is called it was called the inbetweenss .
I am alone as usual.
I am alone in the net cafe and it charges cheaper than others. I went to the dentists to to some filling and cleaning. When I got home my molar bottom tooth crabbers into pieces. I need to get it filled A.S.A.P .
Sunday, August 12, 2018
Saturday, August 11, 2018
I am using an Android Phone.
Every thing we do nowadays is all sounded my computers. Think again what that means. It can be used to help or destroy.
Photography
Heave you heard a good photographer not a good camera? It is all about skill,not sharp enough is not the point. It is about how one use it. Cheers guys
there maybe times when things go wrong.
Amineptine, sold under the brand name Survector among others, is an atypical antidepressant of the tricyclic antidepressant (TCA) family.[3][4] It acts as a selective and mixed dopamine reuptake inhibitor and releasing agent, and to a lesser extent as a norepinephrine reuptake inhibitor.[3][4]
Amineptine was developed by the French Society of Medical research in the 1960s.[5] Introduced in France in 1978 by the pharmaceutical company Servier,[6] amineptine soon gained a reputation for abuse due to its short-lived, but pleasant, stimulant effect experienced by some patients. (This is to be distinguished from its antidepressant effect, which appears in approximately seven days after commencing treatment.)
After its release into the European market, cases of hepatotoxicity emerged, some serious. This, along with the potential for abuse, led to the suspension of the French marketing authorization for Survector in 1999.[7]
Amineptine was never approved by the U.S. Food and Drug Administration (FDA) for marketing in the United States, meaning that it is not legal to market or sell amineptine for any medical uses in the U.S.
Contents
1 Medical uses
2 Contraindications
2.1 Precautions for use
2.2 Effects on the fetus
3 Side effects
3.1 Dermatological
3.2 Psychiatric
3.3 Cardiovascular
3.4 Hepatic
3.5 Gastrointestinal
3.6 Immunological
4 Pharmacology
4.1 Pharmacodynamics
4.2 Pharmacokinetics
5 Society and culture
5.1 Brand names
6 See also
7 References
Medical uses
Amineptine was approved in France for severe clinical depression of endogenous origin in 1978.[8]
Contraindications
Chorea
Hypersensitivity: Known hypersensitivity to amineptine, in particular antecedents of hepatitis after dosage of the product.
MAO inhibitors
Precautions for use
Warnings and precautions before taking amineptine:[9]
Breast feeding
Children less than 15 year of age
General anaesthesia: Discontinue the drug 24 to 48 hours before anaesthesia.[citation needed]
Official sports/Olympic Games: Prohibited substance.
7 March Official Journal 2000.
Pregnancy (first trimester)[citation needed]
Effects on the fetus
Lacking information in humans
Non-teratogenic in rodents
Side effects
Dermatological
Severe acne due to amineptine was first reported in 1988 by various authors—Grupper, Thioly-Bensoussan, Vexiau, Fiet, Puissant, Gourmel, Teillac, Levigne, to name a few—simultaneously[10][11][12][13][14] in the same issue of Annales de dermatologie et de vénéréologie and in the 12 March 1988 issue of The Lancet.[15] A year later, Dr Martin-Ortega and colleagues in Barcelona, Spain reported a case of "acneiform eruption" in a 54-year-old woman whose intake of amineptine was described as "excessive."[16] One year after that, Vexiau and colleagues reported six women, one of whom never admitted to using amineptine, getting severe acne concentrated in the face, back and thorax, the severity of which varied with the dosage.[17] Most of them were treated unsuccessfully with isotretinoin (Accutane) for about 18 months; two of the three that discontinued amineptine experienced a reduction in cutaneous symptoms, with the least affected patient going into remission.[17]
Psychiatric
Psychomotor excitation can very rarely occur with this drug.
Insomnia
Irritability
Nervousness
Suicidal ideation. Seen early in the treatment, by lifting of psychomotor inhibition.
Abuse and dependence
The risk of addiction is low, but exists nonetheless. Between 1978 and 1988, there were 186 cases of amineptine addiction reported to the French Regional Centres of Pharmacovigilance; an analysis of 155 of those cases found that they were predominantly female, and that two-thirds of cases had known risk factors for addiction.[18] However, a 1981 study of known opiate addicts and schizophrenia patients found no drug addiction in any of the subjects.[19] In a 1990 study of eight amineptine dependence cases, the gradual withdrawal of amineptine could be achieved without problems in six people; in two others, anxiety, psychomotor agitation, and/or bulimia appeared.[20]
Withdrawal
Pharmacodependence is very common with amineptine compared to other antidepressants.[21] A variety of psychological symptoms can occur during withdrawal from amineptine,[22] such as anxiety and agitation.[23]
Cardiovascular
Very rarely:
Arterial hypotension
Palpitations
Vasomotor episode
Hepatic
Amineptine can rarely cause hepatitis, of the cytolytic, cholestatic varieties.[24] Amineptine-induced hepatitis, which is sometimes preceded by a rash, is believed to be due to an allergic reaction.[25] It resolves upon discontinuation of the offending drug.[24] The risk of getting this may or may not be genetically determined.[26]
Additionally, amineptine is known to rarely elevate transaminases, alkaline phosphatase, and bilirubin.[27]
Mixed hepatitis, which is very rare, generally occurs between the 15th and 30th day of treatment. Often preceded by sometimes intense abdominal pains, nausea, vomiting or a rash, the jaundice is variable. Hepatitis is either of mixed type or with cholestatic prevalence. The evolution was, in all the cases, favorable to the discontinuation of the drug. The mechanism is discussed (immunoallergic and/or toxic).[28]
In circa 1994 Spain, there was a case associating acute pancreatitis and mixed hepatitis, after three weeks of treatment.[29]
Lazaros and colleagues at the Western Attica General Hospital in Athens, Greece reported two cases of drug induced hepatitis 18 and 15 days of treatment.[30]
One case of cytolytic hepatitis occurred after ingestion of only one tablet.[31]
Gastrointestinal
Acute pancreatitis (very rare) A case associating acute pancreatitis and mixed hepatitis after three weeks of treatment.[29]
Immunological
In 1989, Sgro and colleagues at the Centre de Pharmacovigilance[32] in Dijon reported a case of anaphylactic shock in a woman who had been taking amineptine.[33]
Pharmacology
Pharmacodynamics
Amineptine[34]
Site Ki (nM) Species Ref
SERT >100,000 (IC50) Rat [35]
NET 10,000 (IC50)
3,560 Rat
Canine [35][36]
[37]
DAT 1,000–1,400 (IC50)
3,330 Rat
Canine [35][38][36]
[37]
5-HT1A >100,000 Rat [39]
5-HT2A 74,000 Rat [39]
α1 >100,000 Rat [39]
α2 >100,000 Rat [39]
β >100,000 Rat [39]
D1 >100,000 Canine [35]
D2 >100,000 Rat/canine [35][39]
H1 >100,000
13,000 Rat
Guinea pig [39]
[40]
mACh >100,000 Rat [39]
Values are Ki (nM), unless otherwise noted. The smaller the value, the more strongly the drug binds to the site.
Amineptine inhibits the reuptake of dopamine and, to a much lesser extent, of norepinephrine.[36][35][41] In addition, it has been found to induce the release of dopamine.[36][35][41] However, amineptine is much less efficacious as a dopamine releasing agent relative to D-amphetamine, and the drug appears to act predominantly as a dopamine reuptake inhibitor.[36][35][41] In contrast to the case for dopamine, amineptine does not induce the release of norepinephrine, and hence acts purely as a norepinephrine reuptake inhibitor.[36][35][41] Unlike other TCAs, amineptine interacts very weakly or not at all with the serotonin, adrenergic, dopamine, histamine, and muscarinic acetylcholine receptors.[39][40][41] The major metabolites of amineptine have similar activity to that of the parent compound, albeit with lower potency.[41]
No human data appear to be available for binding or inhibition of the monoamine transporters by amineptine.[42]
Pharmacokinetics
Peak plasma levels of amineptine following a single 100 mg oral dose have been found to range between 277 and 2,215 ng/mL (818–6,544 nM), with a mean of 772 ng/mL (2,281 nM), whereas maximal plasma concentrations of its major metabolite ranged between 144 and 1,068 ng/mL (465–3,452 nM), with a mean of 471 ng/mL (1,522 nM).[1] After a single 200 mg oral dose of amineptine, mean peak plasma levels of amineptine were around 750 to 940 ng/mL (2,216–2,777 nM), while those of its major metabolite were about 750 to 970 ng/mL (2,216–3,135 nM).[2] The time to peak concentrations is about 1 hour for amineptine and 1.5 hours for its major metabolite.[1][2] The elimination half-life of amineptine is about 0.80 to 1.0 hours and that of its major metabolite is about 1.5 to 2.5 hours.[1][2] Due to their very short elimination half-lives, amineptine and its major metabolite do not accumulate significantly with repeated administration.[1]
Society and culture
Brand names
Amineptine has been sold under a variety of brand names including Survector, Maneon, Directim, Neolior, Provector, and Viaspera.
See also
Medifoxamine
Nomifensine
Tianeptine
References
Lachatre G, Piva C, Riche C, et al. (1989). "Single-dose pharmacokinetics of amineptine and of its main metabolite in healthy young adults". Fundam Clin Pharmacol. 3 (1): 19–26. doi:10.1111/j.1472-8206.1989.tb00026.x. PMID 2714729.
Sbarra C, Castelli MG, Noseda A, Fanelli R (1981). "Pharmacokinetics of amineptine in man". Eur J Drug Metab Pharmacokinet. 6 (2): 123–6. doi:10.1007/bf03189478. PMID 7274306.
Vaugeois JM, Corera AT, Deslandes A, Costentin J (June 1999). "Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor". Pharmacology Biochemistry and Behavior. 63 (2): 285–90. doi:10.1016/S0091-3057(98)00242-1. PMID 10371658.
Dunlop BW, Nemeroff CB (2007). "The role of dopamine in the pathophysiology of depression". Arch. Gen. Psychiatry. 64 (3): 327–37. doi:10.1001/archpsyc.64.3.327. PMID 17339521.
DE Patent 2011806 - NEW TRICYCLIC DERIVATIVES AND PROCESS FOR THEIR MANUFACTURE
Sittig, Marshall (1 April 1988) [1979]. Pharmaceutical Manufacturing Encyclopedia (2nd ed.). Park Ridge, New Jersey, United States American: William Andrew Publishing/Noyes Publications. ISBN 978-0-8155-1144-1. Archived from the original on 23 October 2005. Retrieved 29 October 2005.[page needed]
"Docket No. 02N-0101". U.S. Food and Drug Administration. 2002-04-09. Retrieved 2014-01-30.
Doctissimo (2005). "SURVECTOR - Amineptine" (in French). Retrieved 27 October 2005.
Amineptine Medication - Uses, Side Effects and Precautions of Amineptine. Health-care-information.org. Retrieved on September 28, 2013
Grupper C (1988). "[New iatrogenic acne: acne caused by amineptin (Survector)]". Annales de dermatologie et de vénéréologie (in French). 115 (11): 1174–6. PMID 2977079.
Thioly-Bensoussan D, Charpentier A, Triller R, et al. (1988). "[Iatrogenic acne caused by amineptin (Survector). Apropos of 8 cases]". Annales de dermatologie et de vénéréologie (in French). 115 (11): 1177–80. PMID 2977080.
Vexiau P, Gourmel B, Husson C, et al. (1988). "[Severe lesions of acne type induced by chronic amineptin poisoning: apropos of 6 cases]". Annales de dermatologie et de vénéréologie (in French). 115 (11): 1180–2. PMID 2977081.
Teillac D, Weber MJ, Lowenstein W, de Prost Y (1988). "[Acne caused by Survector]". Annales de dermatologie et de vénéréologie (in French). 115 (11): 1183–4. PMID 2977082.
Lévigne V, Faisant M, Mourier C, et al. (1988). "[Monstrous acne in the adult. Inducer role of Survector?]". Annales de dermatologie et de vénéréologie (in French). 115 (11): 1184–5. PMID 2977083.
Vexiau P, Gourmel B, Julien R, et al. (March 1988). "Severe acne-like lesions caused by amineptine overdose". Lancet. 1 (8585): 585. doi:10.1016/S0140-6736(88)91373-6. PMID 2894512.
Martín-Ortega E, Zamora E, Herrero C, Palou J (1989). "[Acneiform eruption induced by amineptin (Survector)]". Medicina Cutánea Ibero-latino-americana (in Spanish). 17 (6): 414–6. PMID 2534534.
Vexiau P, Gourmel B, Castot A, et al. (1990). "Severe acne due to chronic amineptine overdose". Archives of Dermatological Research. 282 (2): 103–7. doi:10.1007/BF00493467. PMID 2141246.
Castot A, Benzaken C, Wagniart F, Efthymiou ML (1990). "[Amineptin abuse. Analysis of 155 cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance]". Thérapie (in French). 45 (5): 399–405. PMID 2260032.
Deniker P, Lôo H, Zarifian E, et al. (1981). "[Amineptine and amotival syndrome (author's transl)]". L'Encéphale (in French). 7 (1): 59–64. PMID 7227285.
Bertschy G, Luxembourger I, Bizouard P, Vandel S, Allers G, Volmat R (1990). "[Amineptin dependence. Detection of patients at risk. Report of 8 cases]". L'Encéphale (in French). 16 (5): 405–9. PMID 2265603.
Blayac JP, Hillaire-Buys D, Peyrière H (1997). "[Pharmacovigilance of new antidepressants: evaluation of neuro-psychobehavioral disorders]". Thérapie. 52 (2): 117–22. PMID 9231505.
Castot A, Benzaken C, Wagniart F, Efthymiou ML (1990). "[Amineptin abuse. Analysis of 155 cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance]". Thérapie. 45 (5): 399–405. PMID 2260032.
Bertschy G, Luxembourger I, Bizouard P, Vandel S, Allers G, Volmat R (1990). "[Amineptin dependence. Detection of patients at risk. Report of 8 cases]". l'Encephale. 16 (5): 405–9. PMID 2265603.
Bories P, Pomier-Layrargues G, Chotard JP, et al. (December 1980). "[Amineptine-induced cholestatic hepatitis. 5 cases (author's transl)]". La Nouvelle Presse Médicale (in French). 9 (48): 3689–92. PMID 7454584.
Pessayre D, Larrey D (April 1988). "Acute and chronic drug-induced hepatitis". Baillière's Clinical Gastroenterology. 2 (2): 385–422. doi:10.1016/0950-3528(88)90009-7. PMID 3044468.
Larrey D, Pageaux GP (1997). "Genetic predisposition to drug-induced hepatotoxicity". Journal of Hepatology. 26 (Suppl 2): 12–21. doi:10.1016/S0168-8278(97)80492-8. PMID 9204405.
"Questions au Professeur Daniel Dhumeaux" [Drug-induced liver disorders. Questions for Professor Daniel Dhumeaux]. Gastroentérologie Clinique et Biologique (in French). 23 (8–9): 917–20. 1999. PMID 10533145.
Concours Med 1982; 104:5733-5734[verification needed]
Sebastián Domingo JJ, Simón Marco MA, Uribarrena Echebarría R (March 1994). "Hepatic and pancreatic injury associated with amineptine therapy". Journal of Clinical Gastroenterology. 18 (2): 168–9. doi:10.1097/00004836-199403000-00023. PMID 8189020.
Lazaros GA, Stavrinos C, Papatheodoridis GV, Delladetsima JK, Toliopoulos A, Tassopoulos NC (1996). "Amineptine induced liver injury. Report of two cases and brief review of the literature". Hepato-gastroenterology. 43 (10): 1015–9. PMID 8884331.
Jonville AP, Dutertre JP, Autret E (1992). "[Immediate acute hepatic cytolysis after the administration of a single amineptin tablet]". Gastroentérologie Clinique et Biologique (in French). 16 (4): 368. PMID 1397859.
centres-pharmacovigilance.net Archived 8 February 2012 at the Wayback Machine.
Sgro C, Lacroix S, Waldner A, Lacroix M, Ferrut O, Bureau A (1989). "[Anaphylactic shock caused by amineptine. Report of a case]". La Revue de Médecine Interne (in French). 10 (5): 461–2. doi:10.1016/s0248-8663(89)80054-2. PMID 2488491.
Roth BL, Driscol, J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.
Garattini S, Mennini T (1989). "Pharmacology of amineptine: synthesis and updating". Clin Neuropharmacol. 12 Suppl 2: S13–8. doi:10.1097/00002826-198912002-00003. PMID 2698268.
Ceci A, Garattini S, Gobbi M, Mennini T (1986). "Effect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brain". Br. J. Pharmacol. 88 (1): 269–75. doi:10.1111/j.1476-5381.1986.tb09495.x. PMC 1917102 Freely accessible. PMID 3708219.
Nishino S, Mao J, Sampathkumaran R, Shelton J (1998). "Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants". Sleep Res Online. 1 (1): 49–61. PMID 11382857.
Protais P, Arbaoui J, Bakkali EH, Bermejo A, Cortes D (1995). "Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes". J. Nat. Prod. 58 (10): 1475–84. doi:10.1021/np50124a001. PMID 8676127.
Hall H, Sällemark M, Wedel I (1984). "Acute effects of atypical antidepressants on various receptors in the rat brain". Acta Pharmacol Toxicol (Copenh). 54 (5): 379–84. PMID 6464782.
Hall H, Ogren SO (1984). "Effects of antidepressant drugs on histamine-H1 receptors in the brain". Life Sci. 34 (6): 597–605. doi:10.1016/0024-3205(84)90494-6. PMID 6141518.
Garattini S (1997). "Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review". Int Clin Psychopharmacol. 12 Suppl 3: S15–9. doi:10.1097/00004850-199707003-00003. PMID 9347388.
Andersen J, Kristensen AS, Bang-Andersen B, Strømgaard K (2009). "Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters". Chem. Commun. (25): 3677–92. doi:10.1039/b903035m. PMID 19557250.
Atarax my sleep companion
I have been taking 50mg of Atarax (Hydroxyzine). I found out that when I take too much, I can't sleep and have rebound action, making me sleepy but being unable to have any Rapid eye movement stage 1. It makes me feel uncomfortable. But I have an addictive nature That's why I prefer Atarax
Friday, August 10, 2018
I am Back to the cozy internet cafe.
I am back to the internet cafe. I prefer here because of the ambience. It makes me happier.
Thursday, August 9, 2018
The Gaba capcills seem to work we'll today.
I am less depress after my medication just starting to work.I hope they will not take or do anything to my medication.
I need it now
:AFTER NOTE:Gabapentin works pretty well too so I Will hang in there.
I am feeling depress.
Feelings of depression is really a hard thing to take. Replacing the feelings with substance is not the the way to carry on(Prozac)Etc........ Dirty Mood Brighteners. I want to be Set free.
Cyber Cafe.
I am now in the Cyber Cafe with my wife and Friend. My Friend enjoys the place as for my wife is Facebook. And me Gaming and Blogging.
Tommy, Kim and Me.
Wednesday, August 8, 2018
Setting up my home Network.
I am too tired to do this now. Maybe when I have the time. It is good so far.
I am back a the net cafe
My friend ask me if I Wanted to go to the Net Cafe. I said OK. Being in the internet cafe is something I have been doing for years.
Tuesday, August 7, 2018
Gabapentin does me good?
I am on this medicine for sometime but I feel the effects of the pill was extracted off a lot.
My new spectater
I have damage 5 to 7 specs in a year. I got to take care of my specs so as not let my Dad spent so much on specs alone.
I feel that this brand of mouthwash is good.
I have been using this brand of mouthwash for sometime and I find it good.
Monday, August 6, 2018
Fear...
I 100% percent believe that U.S.A knows who the killer is. But there is something called fear and it is natural for normal people. As I experience it before. Anyway it is history and we got to get along with life.
More about networking
Web Servers and the Internet some information
The Internet is nothing more than a large collection of computers attached to a telecommunications network and a set of protocols that establishes the rules for data to be sent and received by them. Most computers are linked to the Internet through a modem that directs traffic to and from a local phone or cable company. An Internet service provider (ISP) directs the incoming and outgoing data through a local hub to regional hubs.
All the data that makes up a website is located on one or more specialized computers known as servers. Servers can be expensive to purchase and maintain, so companies, known as domain hosts or website hosts, lease server resources to subscribers in return for monthly fees. This allows most anyone to create a website that is available to the public on the World Wide Web (WWW), which is the collective network of all websites in the world that can be accessed through the Internet.
In order for computers to understand each other, universal codes and protocols have been established. One of the most important of these protocols for websites and domain hosting is hypertext transfer protocol (HTTP). It is this protocol that allows queries to be sent to specific servers so that the websites on those servers can be accessed.
To direct a request for access from a client computer to a website server, a system of names attached to Internet protocol (IP) addresses is in operation. The physical location of the server of a particular website is embedded in the name, which is also known as the uniform resource locator (URL).
Names and IP Addresses
The first step in acquiring a host is to register a name. These are regulated and maintained by name registrars, which ensure that there is no repetition. The actual registration can be done directly through the registrar but most likely will be done by a third party like a hosting service. They are easily readable by people, but for computers to understand them, domain names have to be linked to binary IP addresses through special servers called domain name servers (DNS). This system allows for a them to be transferred to another server should the webmaster decide to use a different platform.
I am back on Valium but it feels different from Alex su
I am back on diaepam and it makes me feel better. As I mentioned I was taking benzodiapines when I was 16 I still remember my dose of Nitrazepam,Diazepam,Fluraezpam ,Lorzepam.........But taking too much and stopping it will cause fits. I still remember I take in big amounts but if I have a appointment with him,the next day I have withdrawal the night beforehand. Now I am not as good looking when I was younger
Subscribe to:
Posts (Atom)